Howard Fingert, M.D.
Senior Medical Director, Clinical Intelligence and Business Development
Dr. Fingert has worked in the biotech/pharma industry for over 20 years after serving in academic faculty positions at Harvard and Tufts medical schools. He has published works in cancer biomarkers, pharmacology, drug safety and phases 1-4 clinical trials.
He currently serves on the American Association for Cancer Research Subcommittee for Regulatory Science and Policy, and recently served as industry representative to the U.S. Federal Drug Administration’s Oncology Drugs Advisory Committee.